Orchid vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-09-01
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionOrchidIsomorphic Labs
PricingFreemiumContact for pricing
Target AudienceIndependent mental health professionalsLarge pharma companies
Core TechnologyGenerative AI for clinical documentationPredictive and generative AI for drug discovery
Key FeatureAI-generated SOAP notes from recordingsDrug Design Engine based on AlphaFold
Partnership ModelIndividual practitioners and groupsDeep pharma collaborations (Novartis, J&J)
Latest News2026-06-18: 10k GitHub repos distributing Trojan malware discovered2026-05-12: Series B funding announced

Orchid and Isomorphic Labs serve completely different markets: Orchid is a freemium AI EHR for mental health clinicians, while Isomorphic Labs is a high-capital pharma AI platform. Your choice depends on your field: mental health practitioners should evaluate Orchid's note automation and billing; pharma R&D leaders should consider Isomorphic's AlphaFold-based partnerships. The latest news reveals an Orchid security issue (malware in GitHub repos) and Isomorphic's continued funding momentum.

Orchid
Orchid

AI-native EHR that automates clinical documentation for mental health professionals

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-native drug discovery partner building on AlphaFold for pharma R&D.

Visit Website
Pricing
Freemium
Contact Sales
Plans
$0 for 1 month
$49/mo
$99/mo
Popularity
1 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
WebMobile
Categories
🏥 Healthcare🧾 Healthcare Revenue Cycle📅 Calendar & Scheduling
🧬 Drug Discovery & Life Sciences
Features
AI-generated SOAP notes
Automated progress notes
Voice-to-text transcription
Intelligent billing code suggestions
Automated superbill generation
Patient scheduling and reminders
Secure patient messaging and portal
Built-in provider profiles and referrals
Payment processing with low fees
HIPAA-compliant cloud platform
Customizable rates and intake forms
Group practice management tools
Business analytics and reporting
One-click claim submission
Integration with major clearinghouses
Drug Design Engine for generative molecule design
Predictive and generative AI models for drug discovery
AlphaFold-based structure prediction
Simulation of drug behavior and performance
End-to-end research collaborations from target to lead
Digital biology simulation at scale
Bioresilience framework for pandemic preparedness
Collaborative R&D with major pharma partners
Target identification and lead optimization support
US operations since 2025
Integrations
Change Healthcare
Office Ally
Zoom
Doxy.me
Stripe
Google Calendar
Outlook Calendar

What real users say: Orchid vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Orchid

87 mentions across 6 sources · 37% positive — critical

Hacker News, YouTube, Product Hunt, GitHub, Lemmy, Tech Press

What users praise

  • AI-driven SOAP notes and progress notes save documentation time.
  • Voice-to-text transcription simplifies note-taking during or after sessions.
  • Automated superbill generation and billing codes reduce admin burden.
  • Built-in patient portal supports scheduling, messaging, and payments.

What frustrates them

  • No community-validated evidence of reliability or clinical effectiveness.
  • Early access means limited track record; potential for bugs and changes.
  • Name collision with other Orchid products causes confusion among users.
  • Marketing video criticized as alienating and attention-seeking, not user-focused.

Researched Aug 16, 2026

Isomorphic Labs

46 mentions across 3 sources · 73% positive

Hacker News, YouTube, Lemmy

What users praise

  • Backed by DeepMind's AlphaFold legacy and Nobel-winning science.
  • Massive pharma partnerships: Novartis, J&J, Eli Lilly.
  • Drug Design Engine (July 2026) moves beyond structure prediction.
  • Generative AI for molecule design, simulating drug behavior.

What frustrates them

  • Not a self-serve tool; partnership-only model limits access.
  • CASP16 shows no clear advantage over older prediction methods.
  • Clinical outcomes unproven; no approved drugs yet.
  • Returns tied to performance milestones, uncertain timeline.

Researched Aug 26, 2026

Who should pick which

  • Solo therapist
    Pick: Orchid

    Orchid's freemium AI EHR is designed for independent mental health professionals, automating notes and billing to save time.

  • Small group practice (mental health)
    Pick: Orchid

    Supports multi-provider group management, customizable templates, and integrates with scheduling and telehealth platforms.

  • Large pharma R&D team
    Pick: Isomorphic Labs

    Isomorphic's AlphaFold-based Drug Design Engine and pharma partnerships are suited for large-scale drug discovery projects.

  • Telehealth-focused clinician
    Pick: Orchid

    Integrates with Zoom and Doxy.me, and includes AI note-taking from session recordings.

  • Academic researcher in drug discovery
    Pick: Isomorphic Labs

    Isomorphic's predictive models for protein-ligand interactions are cutting-edge, but access requires a partnership or contact.

Frequently Asked Questions

Orchid vs Isomorphic Labs: which should you choose?

Orchid and Isomorphic Labs serve completely different markets: Orchid is a freemium AI EHR for mental health clinicians, while Isomorphic Labs is a high-capital pharma AI platform. Your choice depends on your field: mental health practitioners should evaluate Orchid's note automation and billing; pharma R&D leaders should consider Isomorphic's AlphaFold-based partnerships. The latest news reveals an Orchid security issue (malware in GitHub repos) and Isomorphic's continued funding momentum.

Are Orchid and Isomorphic Labs direct competitors?

No, they target entirely different markets: mental health practices vs. pharmaceutical drug discovery.

What is Orchid's latest security issue?

On 2026-06-18, OrchidFiles reported 10k GitHub repositories distributing Trojan malware related to Orchid, which may pose a risk to users.

How does Isomorphic Labs make money?

Through deep pharma collaborations, such as partnerships with Novartis and Johnson & Johnson, not via software licensing.

Can I use Isomorphic Labs as an individual researcher?

No, Isomorphic Labs partners with large pharma companies and is not available as a self-service platform.

Does Orchid support insurance billing?

Yes, it offers intelligent billing code suggestions and automated claim submission integrated with Change Healthcare and Office Ally.

What is Isomorphic Labs' Drug Design Engine?

A platform combining predictive and generative AI to simulate protein-ligand interactions and design novel molecules, built on AlphaFold.

Is Orchid HIPAA compliant?

Yes, it claims HIPAA-compliant cloud and on-device processing.

What funding has Isomorphic Labs raised?

A $600M external investment round in 2025 and a Series B in 2026 (amount undisclosed).

More Orchid or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026